Published : Jul-2017
No. of Pages : 37
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Chronic Obstructive Pulmonary Disease: Executive Summary 4
2.1 Related Reports 6
3 Epidemiology 7
3.1 Disease Background 7
3.2 Risk Factors and Comorbidities 8
3.3 Global and Historical Trends 9
3.4 Forecast Methodology 11
3.4.1 Sources 13
3.4.2 Forecast Assumptions and Methods 15
3.4.3 Total Prevalent Cases 16
3.4.4 Diagnosed Prevalent Cases 18
3.4.5 Diagnosed Prevalent Cases of COPD by Severity 21
3.5 Epidemiological Forecast for COPD (2015-2025) 22
3.5.1 Total Prevalent Cases of COPD 22
3.5.2 Age-Specific Total Prevalent Cases of COPD 23
3.5.3 Sex-Specific Total Prevalent Cases of COPD 25
3.5.4 Diagnosed Prevalent Cases of COPD 26
3.5.5 Age-Specific Diagnosed Prevalent Cases of COPD 27
3.5.6 Sex-Specific Diagnosed Prevalent Cases of COPD 28
3.5.7 Diagnosed Prevalent Cases of COPD by Severity 29
3.6 Discussion 30
3.6.1 Epidemiological Forecast Insight 30
3.6.2 Limitations of Analysis 31
3.6.3 Strengths of Analysis 31
4 Appendix 32
4.1 Bibliography 32
4.2 About the Authors 35
4.2.1 Epidemiologist 35
4.2.2 Reviewers 35
4.2.3 Global Director of Therapy Analysis and Epidemiology 36
4.2.4 Global Head and EVP of Healthcare Operations and Strategy 36
4.3 About GlobalData 36
4.4 Contact Us 37
4.5 Disclaimer 37
1.1 List of Tables
Table 1: Risk Factors and Comorbidities for COPD 9
Table 2: New GOLD 2011 Criteria for COPD Severity Stages 12
Table 3: 8MM, Total Prevalent Cases of COPD, Both Sexes, Ages ?35 Years, N, Selected Years 2015-2025 23
Table 4: 8MM, Age-Specific Total Prevalent Cases of COPD, Both Sexes, N, 2015. 24
Table 5: 8MM, Diagnosed Prevalent Cases of COPD, Both Sexes, Ages ?35 Years, N, Selected Years 2015-2025 26
Table 6: 8MM, Age-Specific Diagnosed Prevalent Cases of COPD, Both Sexes, N, 2015 27
1.2 List of Figures
Figure 1: 8MM, Total Prevalent Cases of COPD, Both Sexes, Ages ?35 Years, 2015 and 2025 5
Figure 2: 8MM, Diagnosed Prevalent Cases of COPD, Both Sexes, Ages ?35 Years, 2015 and 2025 6
Figure 3: 8MM, Age-Standardized Total Prevalence of COPD (%), Ages ?35 Years, 2015 10
Figure 4: 8MM, Age-Standardized Diagnosed Prevalence of COPD (%), Ages ?35 Years, 2015 11
Figure 5: 8MM, Sources Used and Not Used to Forecast Total Prevalent Cases of COPD 13
Figure 6: 8MM, Sources Used and Not Used to Forecast Diagnosed Prevalent Cases of COPD 14
Figure 7: 8MM, Sources Used to Forecast the new GOLD 2011 Severity Stages Among the Diagnosed Prevalent Cases of COPD 15
Figure 8 : 8MM, Age-Specific Total Prevalent Cases of COPD, Both Sexes, N, 2015 24
Figure 9: 8MM, Sex-Specific Total Prevalent Cases of COPD, Both Sexes, N, 2015 25
Figure 10: 8MM, Age-Specific Diagnosed Prevalent Cases of COPD, Both Sexes, N, 2015 27
Figure 11: 8MM, Sex-Specific Diagnosed Prevalent Cases of COPD, Both Sexes, N, 2015 28
Figure 12: 8MM, Diagnosed Prevalent Cases of COPD by the GOLD Severity Stage (Using mMRC), Both Sexes, 2015 29
Figure 13: 8MM, Diagnosed Prevalent Cases of COPD by the GOLD Severity Stage (Using CAT), Both Sexes, 2015 30
